Clean Power Hydrogen Level 1 of Factory Acceptance Test Completed

RNS Number : 3342U

Clean Power Hydrogen

28 June 2024

 

 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 which is part of UK law by virtue of the European Union (withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

 28 June 2024

 

Clean Power Hydrogen plc

("CPH2", the "Company" or the "Group")

 

Level 1 of Factory Acceptance Test Completed

 

CPH2, the UK-based green hydrogen technology and manufacturing company that has developed the IP-protected Membrane-Free Electrolyser ("MFE"), is pleased to announce the successful completion of Level 1 of the Factory Acceptance Test ("FAT") for its MFE110 electrolyser. The completion of the MFE110 Level 1 FAT marks the first of three stages within the FAT which run sequentially, with completion of FAT marking the significant juncture of the MFE110 becoming a commercially accepted electrolyser.

 

The Level 1 FAT signifies a crucial part of the procedure verifying that mechanical and electrical components are checked for completion, confirms that all documentation is in order, and that the MFE's design and build is aligned to the documentation and compliant to relevant safety standards. The successful independent verification was undertaken by Lagan MEICA Limited, the Contractor to Northern Ireland Water.

 

The Company is now proceeding with Level 2 of the FAT protocol, which verifies a broad range of checks and calibrations for the MFE110. Once the functional checks of the MFE110 are completed, CPH2 will begin Level 3 FAT, the final testing procedure once the MFE110 electrolyser has been fully commissioned and is producing hydrogen and oxygen.

 

The completed FAT of the MFE110 will be the first customer acceptance and validation of CPH2's scaled electrolyser technology marking a significant milestone in the Company's route to market.

 

 

Jon Duffy, CEO commented:

"The completion of Level 1 FAT is an important milestone as we continue with the Factory Acceptance Testing of our market-leading technology. Level 1 signifies that we have completed the build of the MFE110 and all necessary checks are complete so we can continue our journey to commercialisation. We will now swiftly move to Level 2 where upon approval of the functional checks, we will commence our final stage, on-site testing of the MFE110."

 

ENDS

 

 

For more information, please contact:

 

Clean Power Hydrogen plc	via Camarco
Jon Duffy, Chief Executive Officer James Hobson, Chief Financial Officer
Cavendish Capital Markets Limited - NOMAD & Broker
Neil McDonald	[phone]
Peter Lynch	[phone]
Adam Rae	[phone]
Camarco PR	+ 44(0) 20 3 757 4980
Billy Clegg
Owen Roberts
Lily Pettifar

 

To find out more, please visit: https://www.cph2.com

 

Overview of CPH2

CPH2 is the holding company of Clean Power Hydrogen Group Limited which has almost a decade of dedicated research and product development experience. This experience has resulted in the creation of simple, safe and sustainable technology which is designed to deliver a modular solution to the hydrogen production market in a cost-effective, scalable, reliable and long-lasting manner. The Group's strategic objective is to deliver the lowest LCOH in the market in relation to the production of green hydrogen. CPH2 is listed on the AIM market and trades under the ticker LON:CPH2.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

UPDDVLBLZQLBBBV